Bone Biologics Corporation (BBLG)
NASDAQ
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Operating Income | -1.22M | -1.29M | -3.15M | -3.04M | -2.08M | -1.16M | -903k | -810k |
Pre Tax Income | -1.22M | 891k | -3.71M | -1.77M | -1.92M | -1.55M | -866k | -784k |
Net Income | -1.22M | 893k | -3.71M | -1.77M | -1.92M | -1.55M | -866k | -784k |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Basic Earnings Per Share (EPS) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EBIT | -1.22M | -2.02M | -3.15M | -3.04M | -2.08M | -1.16M | -903k | -810k |
EBITDA | -1.22M | -1.29M | -3.15M | -3.04M | -2.08M | -1.16M | -903k | -810k |
Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Operating Income | -17.85M | -2.63M | -2.79M | -2.45M | -825k | -1.1M | -3.67M | -9.43M |
Pre Tax Income | -21.03M | -7.05M | -4.43M | -3.42M | -1.82M | -1.61M | -1.49M | -8.95M |
Net Income | -21.03M | -7.05M | -4.43M | -3.43M | -1.83M | -1.61M | -1.49M | -8.95M |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Basic Earnings Per Share (EPS) | -0.542 | -0.163 | -0.167 | -0.112 | -0.059 | -0.156 | -0.097 | -2.855 |
EBIT | -17.85M | -2.63M | -3.2M | -2.45M | -825k | -1.1M | -4.4M | -9.43M |
EBITDA | -17.85M | -2.63M | -2.79M | -2.45M | -825k | -1.1M | -3.67M | -9.43M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.